Pedro Lichtinger
Director/Board Member at ZERO GRAVITY SOLUTIONS, INC.
Profile
Pedro Lichtinger is the founder of Starton Therapeutics, Inc. founded in 2017, where he is currently the Chairman & Chief Executive Officer.
He is also currently the Chairman & Chief Executive Officer of HWEL Holdings Corp., Director of Boys & Girls Clubs of America, Director of Zero Gravity Solutions, Inc., Director of Laboratorios Sanfer SA de CV, Director of Brazil Foundation, and Director of ChemioCare, Inc. In his former positions, he was the President, Chief Executive Officer & Director of Asterias Biotherapeutics, Inc. from 2014 to 2016, President, Chief Executive Officer & Director of Optimer Pharmaceuticals LLC from 2011 to 2013, and Independent Director of Lineage Cell Therapeutics, Inc. from 2011 to 2014.
He was also a Director of Velcera LLC and an Independent Director of Gemphire Therapeutics, Inc. from 2015 to 2019.
Mr. Lichtinger's education includes an undergraduate degree from Universidad Nacional Autónoma de México and an MBA from The Wharton School of the University of Pennsylvania.
Pedro Lichtinger active positions
| Companies | Position | Start |
|---|---|---|
| ZERO GRAVITY SOLUTIONS, INC. | Director/Board Member | - |
Boys & Girls Clubs of America
 Boys & Girls Clubs of America Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of America offers school programs. The firm's programs include character and leadership, education and career, health & life skills, the arts, sports, fitness and recreation. Boys & Girls Clubs of America was founded in 1860 and is headquartered in Atlanta, GA. | Director/Board Member | - |
Laboratorios Sanfer SA de CV
 Laboratorios Sanfer SA de CV Pharmaceuticals: MajorHealth Technology Laboratorios Sanfer SA de CV manufactures and supplies pharmaceutical products. Its brands include Alquimid, Andantol, Astelin, Clavulin, Coversyl and Daflon. The company was founded by Santovena and Fernandez in 1941 and is headquartered in Mexico City, Mexico. | Director/Board Member | - |
| Brazil Foundation | Director/Board Member | - |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Chief Executive Officer | 2016-12-31 |
Former positions of Pedro Lichtinger
| Companies | Position | End |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director/Board Member | 2019-12-29 |
| ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 2016-02-28 |
| LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 2014-11-03 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Pedro Lichtinger
| Universidad Nacional Autónoma de México | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| ZERO GRAVITY SOLUTIONS, INC. | Technology Services |
| Private companies | 10 |
|---|---|
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Boys & Girls Clubs of America
Boys & Girls Clubs of America Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of America offers school programs. The firm's programs include character and leadership, education and career, health & life skills, the arts, sports, fitness and recreation. Boys & Girls Clubs of America was founded in 1860 and is headquartered in Atlanta, GA. | Commercial Services |
Velcera LLC
 Velcera LLC Pharmaceuticals: MajorHealth Technology Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA. | Health Technology |
Laboratorios Sanfer SA de CV
Laboratorios Sanfer SA de CV Pharmaceuticals: MajorHealth Technology Laboratorios Sanfer SA de CV manufactures and supplies pharmaceutical products. Its brands include Alquimid, Andantol, Astelin, Clavulin, Coversyl and Daflon. The company was founded by Santovena and Fernandez in 1941 and is headquartered in Mexico City, Mexico. | Health Technology |
| Brazil Foundation | |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
- Stock Market
- Insiders
- Pedro Lichtinger
